Price Alert

Foghorn Therapeutics Inc. (FHTX)

NASDAQ: FHTX · Real-Time Price · USD

5.06

-0.08 (-1.65%)

At close: Aug 15, 2025, 2:35 PM

-1.65% (1D)

Bid	5.06
Market Cap	286.09M
Revenue (ttm)	24.17M
Net Income (ttm)	-75.39M
EPS (ttm)	-1.14
PE Ratio (ttm)	-4.44
Forward PE	-3.77
Analyst	Buy

Ask	5.14
Volume	38,971
Avg. Volume (20D)	127,138
Open	5.18
Previous Close	5.14
Day's Range	4.99 - 5.18
52-Week Range	2.94 - 10.25
Beta	3.06

About FHTX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol FHTX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for FHTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Foghorn Therapeutics has released their quartely earnings on Aug 5, 2025:

Revenue of $7.56M exceeds estimates by $250.92K, with 9.71% YoY growth.

EPS of -0.28 exceeds estimates by 0.03, with 37.78% YoY growth.

Next Earnings Release

Foghorn Therapeutics Inc. is scheduled to release its earnings on Nov 3, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

8 months ago

+3.96%

Foghorn Therapeutics shares rare trading lower aft... Unlock content with Pro Subscription

News

6 days ago · zacks.com

Here's Why Foghorn Therapeutics (FHTX) Looks Ripe for Bottom Fishing

Foghorn Therapeutics (FHTX) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions cou...

1 week ago · zacks.com

Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Lags Revenue Estimates

Foghorn Therapeutics Inc. (FHTX) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to a loss of $0.45 per share a year ago.